ONE TABLET DAILY
Once-daily RELEXXII simplifies ADHD treatment with its extended release formulation made possible by Osmodex Drug Delivery Technology.1,2
WHY CHOOSE ONCE-DAILY RELEXXII
Once-daily RELEXXII (methylphenidate hydrochloride extended-release tablets) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults up to the age of 65 years and pediatric patients 6 years of age and older.1
-
-
SEVEN STRENGTHS
RELEXXII provides the power to choose from seven strengths in support of individual needs throughout the ADHD treatment journey.
-
TWO “IN-BETWEEN” STRENGTHS
RELEXXII 45-mg and 63-mg provide two "in-between" strengths, specifically designed to help achieve the lowest effective dose for symptom management.
-
9-MG INCREMENTS
The wide range of strengths provides the option to more gradually increase or decrease RELEXXII, in 9-mg increments, to support a more tailored treatment approach through dose optimization.
References: 1. RELEXXII (methylphenidate hydrochloride extended-release tablets) package insert. Vertical Pharmaceuticals, LLC; 2023. 2. Data on file, Osmotica Pharmaceuticals.
*Co-pay assistance is applicable to prescription coverage for eligible commercially insured patients. Offer void where prohibited. No income restrictions apply. Other restrictions may apply. Offer effective 04/2024. Alora Pharmaceuticals, LLC reserves the right to rescind, revoke, or amend this offer without notice. For full terms and conditions, click here.
All individuals depicted are models used for illustrative purposes only.